(Q30810168)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12849150%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

review article

1 reference

title

The use of quantitative magnetic-resonance-based techniques to monitor the evolution of multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12849150%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12849150%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Maria A Rocca

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12849150%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

3

Giancarlo Comi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12849150%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 June 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12849150%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12849150%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12849150%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12849150%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

337-346

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12849150%20AND%20SRC:MED&resulttype=core&format=json

Magnetic resonance techniques to monitor disease evolution and treatment trial outcomes in multiple sclerosis

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Clinical-MRI correlations in a European trial of interferon beta-1b in secondary progressive MS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Overview of diffusion-weighted magnetic resonance studies in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Functional brain mapping by blood oxygenation level-dependent contrast magnetic resonance imaging. A comparison of signal characteristics with a biophysical model

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Serial magnetisation transfer ratios in gadolinium-enhancing lesions in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Magnetization transfer ratios in multiple sclerosis lesions enhancing after different doses of gadolinium

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

A serial study of new MS lesions and the white matter from which they arise

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Early structural changes in acute MS lesions assessed by serial magnetization transfer studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Serial magnetization transfer imaging to characterize the early evolution of new MS lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Magnetization transfer ratios of multiple sclerosis lesions with variable durations of enhancement

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Multiple sclerosis: magnetization transfer MR imaging of white matter before lesion appearance on T2-weighted images

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Quantitative magnetization transfer imaging of pre-lesional white-matter changes in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Studies on the pathogenesis of multiple sclerosis. Participation of lysosomes on demyelination in the central nervous system white matter outside plaques.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Microscopic disease in normal-appearing white matter on conventional MR images in patients with multiple sclerosis: assessment with magnetization-transfer measurements

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

A Magnetization Transfer Imaging Study of Normal-Appearing White Matter in Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Magnetization transfer imaging of patients with definite MS and negative conventional MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Quantitative volumetric magnetization transfer analysis in multiple sclerosis: estimation of macroscopic and microscopic disease burden.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Brain atrophy in multiple sclerosis: impact of lesions and of damage of whole brain tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Magnetization transfer imaging to monitor the evolution of MS: A 1-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Magnetization transfer histogram parameters reflect all dimensions of MS pathology, including atrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Correlation of volumetric magnetization transfer imaging with clinical data in MS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Correlations between clinical and MRI involvement in multiple sclerosis: assessment using T1, T2 and MT histograms

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

A magnetization transfer histogram study of normal-appearing brain tissue in MS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Normal-appearing brain tissue MTR histograms in clinically isolated syndromes suggestive of MS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Adaptive functional changes in the cerebral cortex of patients with nondisabling multiple sclerosis correlate with the extent of brain structural damage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Diffuse axonal and tissue injury in patients with multiple sclerosis with low cerebral lesion load and no disability

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Magnetization transfer can predict clinical evolution in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

The distribution of plaques in the cerebrum in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Cortical lesions in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Magnetisation transfer ratio and mean diffusivity of normal appearing white and grey matter from patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Magnetization transfer and diffusion tensor MR imaging of basal ganglia from patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Cerebral grey matter pathology and fatigue in patients with multiple sclerosis: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Magnetization transfer ratio histogram analysis of normal-appearing gray matter and normal-appearing white matter in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Magnetization transfer ratio in new MS lesions before and during therapy with IFNbeta-1a

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

The effect of interferon beta-1b on quantities derived from MT MRI in secondary progressive MS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

A conventional and magnetization transfer MRI study of the cervical cord in patients with MS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Magnetisation transfer ratios and transverse magnetisation decay curves in optic neuritis: correlation with clinical findings and electrophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Irreversible disability and tissue loss in multiple sclerosis: a conventional and magnetization transfer magnetic resonance imaging study of the optic nerves

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Relative contributions of brain and cervical cord pathology to multiple sclerosis disability: a study with magnetisation transfer ratio histogram analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Imaging of diffusion and microcirculation with gradient sensitization: Design, strategy, and significance

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Estimation of the effective self-diffusion tensor from the NMR spin echo

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Diffusion tensor MR imaging of the human brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

In vivo magnetic resonance diffusion measurement in the brain of patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Increased water self-diffusion in chronic plaques and in apparently normal white matter in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Apparent diffusion coefficients in benign and secondary progressive multiple sclerosis by nuclear magnetic resonance

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Comparison of multiple sclerosis clinical subgroups using navigated spin echo diffusion-weighted imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

A quantitative study of water diffusion in multiple sclerosis lesions and normal-appearing white matter using echo-planar imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Pathologic damage in MS assessed by diffusion-weighted and magnetization transfer MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Weekly diffusion-weighted imaging of normal-appearing white matter in MS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis: a serial diffusion MRI study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Magnetic resonance diffusion tensor imaging for characterizing diffuse and focal white matter abnormalities in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Quantitative diffusion measurements in focal multiple sclerosis lesions: correlations with appearance on TI-weighted MR images

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Diffusion tensor magnetic resonance imaging in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Multiple sclerosis: diffusion tensor MR imaging for evaluation of normal-appearing white matter.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

A longitudinal study of MR diffusion changes in normal appearing white matter of patients with early multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Whole-brain diffusion MR histograms differ between MS subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Cognitive dysfunction in patients with mildly disabling relapsing-remitting multiple sclerosis: an exploratory study with diffusion tensor MR imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Magnetic resonance imaging, magnetisation transfer imaging, and diffusion weighted imaging correlates of optic nerve, brain, and cervical cord damage in Leber's hereditary optic neuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Assessment of normal-appearing white and gray matter in patients with primary progressive multiple sclerosis: a diffusion-tensor magnetic resonance imaging study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Correlates of MS disability assessed in vivo using aggregates of MR quantities.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Diffusion-weighted imaging of the human optic nerve: a new approach to evaluate optic neuritis in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

ADC mapping of the human optic nerve: Increased resolution, coverage, and reliability with CSF-suppressed ZOOM-EPI

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Diffusion imaging of the spinal cord in vivo: estimation of the principal diffusivities and application to multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Investigating cervical spinal cord structure using axial diffusion tensor imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Chemical pathology of acute demyelinating lesions and its correlation with disability

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Reversible decreases in N-acetylaspartate after acute brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal-appearing white matter of multiple sclerosis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Preliminary evidence for neuronal damage in cortical grey matter and normal appearing white matter in short duration relapsing-remitting multiple sclerosis: a quantitative MR spectroscopic imaging study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Localized (1)H magnetic resonance spectroscopy in mainly cortical gray matter of patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Thalamic neurodegeneration in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Axonal injury or loss in the internal capsule and motor impairment in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Cognitive dysfunction lateralizes with NAA in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Total brain N-acetylaspartate concentration in normal, age-grouped females: quantitation with non-echo proton NMR spectroscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Total brain N-acetylaspartate: a new measure of disease load in MS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Proton MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Quantitative 1H MRS imaging 14 years after presenting with a clinically isolated syndrome suggestive of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Relapsing-remitting multiple sclerosis and whole-brain N-acetylaspartate measurement: evidence for different clinical cohorts initial observations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

1H-MRS in patients with multiple sclerosis undergoing treatment with interferon beta-1a: results of a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Recovery from optic neuritis is associated with a change in the distribution of cerebral response to visual stimulation: a functional magnetic resonance imaging study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Evidence for axonal pathology and adaptive cortical reorganization in patients at presentation with clinically isolated syndromes suggestive of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Cortical motor reorganization after a single clinical attack of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Contribution of corticospinal tract damage to cortical motor reorganization after a single clinical attack of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Relating axonal injury to functional recovery in MS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Visual activation patterns in patients with optic neuritis: an fMRI pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Evidence for adaptive functional changes in the cerebral cortex with axonal injury from multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

The motor cortex shows adaptive functional changes to brain injury from multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Functional MRI of the visual cortex and visual testing in patients with previous optic neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Cognitive function and fMRI in patients with multiple sclerosis: evidence for compensatory cortical activation during an attention task.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Evidence for widespread movement-associated functional MRI changes in patients with PPMS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Correlations between structural CNS damage and functional MRI changes in primary progressive MS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

Functional brain reorganization for hand movement in patients with multiple sclerosis: defining distinct effects of injury and disability

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900408-3

7 January 2021

10.1016/S1474-4422(03)00408-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12849150%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference